The European Commission (EC) has approved AstraZeneca ‘s Fasenra (benralizumab) as an add-on therapy for adults with ...

South Korea’s Ministry of Health and Welfare recently disclosed its proposal to revise the drug reimbursement and ...

The registrational trial is expected to support the approval for Bavarian’s mpox/smallpox vaccine use in children 2-11 years ...

At the Outsourcing in Clinical Trials Conference, US government personnel advised attendees on the transport of biologics ...

Organon has completed the acquisition of Dermavant Sciences, a subsidiary of Roivant, to expand its dermatology portfolio.

The SIRT6 activator’s sex-specific effects shed light on the different genetic profiles of depression between men and women.

As the retail drug pharmacy space undergoes significant change, new formats and designs that centre on the consumer are ...

The US FDA has approved Iterum Therapeutics' NDA for ORLYNVAH to treat uncomplicated urinary tract infections (uUTIs).

The US FDA has granted orphan drug designation (ODD) to Modalis Therapeutics’ MDL-101, aimed at treating LAMA2-CMD.

UPFs have become a staple of many diets worldwide, but overconsumption is contributing to an obesity epidemic in India.

At the Outsourcing in Clinical Trials conference, Rohan Simon from the UAE CRO IROS, spoke about the region’s clinical trials ...

Motivated patients with rare diseases are using social media widely, making it an effective way to reach patients for trial ...